Clinical Trial Update: A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study of recombinant botulinum toxin type A (YY001) for treating upper limb spasticity in adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Limb Spasticity

Drugs mentioned

• YY001

Snippet

Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd. | Conditions: Upper Limb Spasticity | Phase 2, Phase 3 | Status: RECRUITING